Ditchcarbon
  • Contact
  1. Organizations
  2. Ranbaxy Laboratories Ltd.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
IN
updated 7 months ago

Ranbaxy Laboratories Ltd.

Company website

Ranbaxy Laboratories Ltd., a prominent player in the pharmaceutical industry, is headquartered in India. Founded in 1961, the company has established itself as a leader in the development and manufacturing of generic and branded medications, with a strong presence in various global markets, including North America, Europe, and Asia. Specialising in a diverse range of therapeutic areas, Ranbaxy offers a unique portfolio of products, including antibiotics, cardiovascular medications, and anti-diabetics. The company is recognised for its commitment to quality and innovation, having achieved significant milestones such as the introduction of several first-to-file generic drugs. With a robust market position, Ranbaxy has garnered numerous accolades for its contributions to healthcare, making it a trusted name in the pharmaceutical sector. Its dedication to research and development continues to drive its success in delivering affordable healthcare solutions worldwide.

DitchCarbon Score

How does Ranbaxy Laboratories Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

58

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Ranbaxy Laboratories Ltd.'s score of 58 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.

76%

Let us know if this data was useful to you

Ranbaxy Laboratories Ltd.'s reported carbon emissions

Inherited from Sun Pharmaceutical Industries Limited

Ranbaxy Laboratories Ltd., headquartered in India, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Sun Pharmaceutical Industries Limited, which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from Ranbaxy Laboratories Ltd. However, emissions data and performance metrics may be inherited from its parent company, Sun Pharmaceutical Industries Limited. This cascading of data suggests that any climate initiatives or targets would align with those set by Sun Pharmaceutical. In the broader context, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt science-based targets and engage in initiatives that promote environmental responsibility. While specific commitments from Ranbaxy are not detailed, the industry trend indicates a growing emphasis on climate action and emissions reduction.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201920202021202220232024
Scope 1
77,616,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
377,728,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ranbaxy Laboratories Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ranbaxy Laboratories Ltd. is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Ranbaxy Laboratories Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Dabur

IN
•
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 19 days ago

Aaron Industries, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Sandoz S.R.L.

RO
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Kalbe International Pte Ltd.

SG
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

P AND L DEVELOPMENT LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated 20 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy